subgroup of
antibody)
→
ReceivesAction
→
approved by the fda
| Typicality: | 0.418 |
| Saliency: | 0.243 |
| since the first | 2 | temporal |
| for targeted cancer treatment | 2 | purpose |
| monoclonal antibody → be approved by → the fda | 3 |
| monoclonal antibody → be approved by → fda | 3 |
| negative | neutral | positive |
| 0.007 | 0.633 | 0.360 |
| Raw frequency | 6 |
| Normalized frequency | 0.243 |
| Modifier score | 0.700 |
| Perplexity | 35.304 |